Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-02 Purchase | 2020-12-04 6:47 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 6,400 | $4.1581 | $26,612 | 10,660,554 (Indirect Direct) | View |
| 2020-11-13 Purchase | 2020-11-17 7:02 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 977 | $4.2089 | $4,112 | 10,647,754 (Indirect Direct) | View |
| 2020-11-10 Purchase | 2020-11-12 6:23 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 2,400 | $3.58 | $8,592 | 10,645,800 (Indirect Direct) | View |
| 2020-11-02 Purchase | 2020-11-04 8:12 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 3,100 | $3.56 | $11,036 | 10,641,000 (Indirect Direct) | View |
| 2020-09-23 Purchase | 2020-09-25 4:57 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 2,000 | $4.07 | $8,140 | 10,634,800 (Indirect Direct) | View |
| 2020-09-18 Purchase | 2020-09-22 5:49 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 3,300 | $4.1348 | $13,645 | 10,630,800 (Indirect Direct) | View |
| 2020-09-16 Purchase | 2020-09-17 6:08 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 530 | $3 | $1,590 | 4,635 (Direct) | View |
| 2020-09-16 Purchase | 2020-09-16 8:43 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 100 | $3.75 | $375 | 25,924,200 (Indirect Direct) | View |
| 2020-08-18 Purchase | 2020-08-20 6:58 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 9,998 | $3.125 | $31,244 | 10,624,000 (Indirect Direct) | View |
| 2020-08-19 Purchase | 2020-08-20 4:18 pm | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,105 | $3 | $12,315 | 4,105 (Direct) | View |
| 2020-07-17 Purchase | 2020-07-21 5:27 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 4,500 | $3 | $13,500 | 10,604,004 (Indirect Direct) | View |
| 2020-01-29 Purchase | 2020-01-31 5:03 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 3,000 | $7.13 | $21,390 | 423,336 (Indirect Direct) | View |
| 2019-12-19 Purchase | 2019-12-23 5:25 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 12,048 | $5.1604 | $62,172 | 417,336 (Indirect Direct) | View |
| 2019-12-16 Purchase | 2019-12-18 5:14 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 3,000 | $5.25 | $15,750 | 393,240 (Indirect Direct) | View |
| 2019-12-09 Purchase | 2019-12-11 5:20 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 2,523 | $5.2009 | $13,122 | 387,240 (Indirect Direct) | View |
| 2019-12-04 Purchase | 2019-12-06 5:34 pm | ReShape Lifesciences Inc. | RSLSD | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 1,929 | $5.1826 | $9,997 | 382,194 (Indirect Direct) | View |
| 2019-11-26 Purchase | 2019-11-27 5:12 pm | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 2,000 | $5.43 | $10,860 | 378,336 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-15 Other | 2021-06-22 08:33 am | N/A 2024-11-12 | ReShape Weightloss Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 17,980,277 | $0 | 5,330,277 (Direct) | View |
| 2021-06-15 Disposition | 2021-06-17 4:06 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer | 4,635 | $3.05 | 0 (Direct) | View |
| 2020-09-14 Other | 2020-09-16 8:43 pm | 2020-09-14 2025-09-14 | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 1,200,000 | $0 | 25,924,200 (Direct) | View |
| 2020-04-13 Exercise | 2020-04-15 4:29 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 0 | $0 | 23,495,004 (Indirect) | View |
| 2020-04-13 Exercise | 2020-04-15 4:29 pm | N/A N/A | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 5,085,834 | $0.12 | 23,495,004 (Direct) | View |
| 2020-03-25 Other | 2020-03-27 5:36 pm | 2020-03-25 2025-03-25 | ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner | 1,200,000 | $0 | 23,071,668 (Direct) | View |